Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock Holdings Boosted by William Blair Investment Management LLC

William Blair Investment Management LLC lifted its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 50.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,972,647 shares of the company's stock after acquiring an additional 999,940 shares during the period. William Blair Investment Management LLC owned 1.55% of Alignment Healthcare worth $33,442,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. R Squared Ltd purchased a new position in shares of Alignment Healthcare during the 4th quarter worth $55,000. Ballentine Partners LLC purchased a new position in Alignment Healthcare during the fourth quarter worth about $121,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Alignment Healthcare in the 3rd quarter valued at about $131,000. Aigen Investment Management LP acquired a new position in shares of Alignment Healthcare during the 4th quarter valued at about $129,000. Finally, AlphaQuest LLC acquired a new stake in shares of Alignment Healthcare in the fourth quarter worth approximately $132,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

Analysts Set New Price Targets

ALHC has been the topic of a number of recent analyst reports. William Blair reaffirmed an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Stifel Nicolaus lifted their target price on Alignment Healthcare from $16.00 to $18.00 and gave the company a "buy" rating in a report on Friday, February 28th. Barclays upped their price target on Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research note on Friday, February 28th. Piper Sandler raised their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a report on Tuesday, March 4th. Finally, Stephens reiterated an "overweight" rating and issued a $17.00 target price on shares of Alignment Healthcare in a research note on Monday, February 24th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $14.83.

Remove Ads

Insider Activity at Alignment Healthcare

In other news, COO Sebastian Burzacchi sold 6,694 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $16.40, for a total value of $109,781.60. Following the sale, the chief operating officer now owns 250,378 shares in the company, valued at approximately $4,106,199.20. This represents a 2.60 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO John E. Kao sold 90,000 shares of Alignment Healthcare stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $13.06, for a total value of $1,175,400.00. Following the completion of the transaction, the chief executive officer now owns 2,273,100 shares of the company's stock, valued at $29,686,686. This trade represents a 3.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,901,665 shares of company stock valued at $29,141,513 over the last ninety days. Corporate insiders own 6.60% of the company's stock.

Alignment Healthcare Stock Up 2.5 %

ALHC stock traded up $0.43 during midday trading on Friday, hitting $17.61. 3,358,496 shares of the company's stock were exchanged, compared to its average volume of 1,424,967. The firm has a 50 day moving average price of $14.90 and a 200-day moving average price of $12.69. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $17.76. The stock has a market capitalization of $3.38 billion, a price-to-earnings ratio of -22.87 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.